Shree Chem planning to set up Active Pharmaceutical Ingredients Project in Gujarat

Shree Chem, an active pharmaceutical ingredient (API) producer in India, intends to expand its operations with a new API project in Kadi, Mahesana, Gujarat. The project is projected to cost ten crores and will employ approximately 1,000 people. The new initiative will concentrate on the development of APIs for cardiovascular, anti-infective, and anti-cancer therapies. Shree Chem is currently a prominent supplier of APIs in these areas, and the new initiative will solidify its position in these industries even further. The project is scheduled to be finished in 2025. 

Here are some of the details of the project: Location: Kadi, Mahesana, Gujarat Cost: 10 Crores Completion: 2024 Products: APIs for cardiovascular, anti-infective, and anti-cancer drugs The expansion of Shree Chem's operations is a positive development for the Indian pharmaceutical industry. It is a sign of the growing demand for APIs in India and the world. Here are some of the benefits of the project: It will create jobs and boost economic activity in the region.

 It will help to meet the growing demand for APIs in India and the world. It will strengthen India's position as a leading player in the global pharmaceutical industry. Shree Chem is a leading manufacturer of APIs in India. The company has a strong track record of innovation and quality. The new project is a testament to Shree Chem's commitment to growth and expansion.

As of September 2023, The project is now in the stage of construction being started the work on the project will be finished in 2024, 2025 or 2026 It has been decided to hire a local contractor.

News by Rahul Yeligetti